Journal article · 2026 · Open access

Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process

Helena Jane Teede, Mahnaz Bahri Khomami, Rachel Morman, Joop S.E. Laven, Anju Elizabeth Joham, Michael Costello, Madhuri Patil, D Aled Rees, Lorna Berry, Melanie G. Cree, Han Zhao, Robert J Norman and 64 more

The Lancet, 407(10545), 2329–2339 · Published 12 May 2026 · DOI 10.1016/s0140-6736(26)00717-8

Open PDFView at the publisherCite this paper

In brief

“Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process” is a 2026 journal article by Helena Jane Teede and 75 co-authors, published in The Lancet. OpenAlex counts 542 citations as of 16 November 2026, which puts it in the top 7% of works published in 2026 by citations. It is open access under a CC BY licence: the full text is free to read at The Lancet.

Citations
542
Most cited in
2026 (539)
Field-weighted impact
1730.44
References
36
Authors
76

Abstract

Polyendocrine metabolic ovarian syndrome (PMOS), previously named polycystic ovary syndrome (PCOS), affects one in eight women. However, the term PCOS is inaccurate, implying pathological ovarian cysts, obscuring diverse endocrine and metabolic features, and contributing to delayed diagnosis, fragmented care, and stigma, while curtailing research and policy framing. Building on an international mandate for change, we outline an unprecedented, rigorous, multistep global consensus process for the name change. Funding and governance were established with engagement of 56 leading academic, clinical, and patient organisations. Using iterative global surveys (with responses from 14 360 people with PCOS and multidisciplinary health professionals from all world regions), modified Delphi methods, nominal group technique workshops, and marketing and implementation analyses, we identified principles prioritising scientific accuracy, clarity, stigma avoidance, cultural appropriateness, and implementation feasibility. An accurate new name was prioritised over retaining the PCOS acronym or a generic name. Implementation approaches prioritised evolution rather than transformation. Preferred terms were polyendocrine, metabolic, and ovarian, reflecting the condition's multisystem pathophysiology, and polyendocrine metabolic ovarian syndrome was the consensus new name. Accuracy was improved by omitting cysts and by capturing endocrine, metabolic, and ovarian dysfunction. A co-designed global implementation strategy, including a transition period, education, and alignment with health systems and disease classification, is under way.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Teede, H. J., Khomami, M. B., Morman, R., Laven, J. S., Joham, A. E., Costello, M., Patil, M., Rees, D. A., Berry, L., Cree, M. G., Zhao, H., Norman, R. J., Dokras, A., Piltonen, T., Amao, S., Amiri, M., Andrews, C., Arcari, A., Arlt, W., . . . Zhang, Y. (2026). Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. The Lancet, 407(10545), 2329–2339. https://doi.org/10.1016/s0140-6736(26)00717-8

MLA 9

Teede, Helena Jane, et al. “Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process.” The Lancet, vol. 407, no. 10545, 2026, pp. 2329–2339. https://doi.org/10.1016/s0140-6736(26)00717-8.

Chicago

Teede, Helena Jane, Mahnaz Bahri Khomami, Rachel Morman, Joop S.E. Laven, Anju Elizabeth Joham, Michael Costello, Madhuri Patil, et al. 2026. “Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process.” The Lancet 407 (10545): 2329–2339. https://doi.org/10.1016/s0140-6736(26)00717-8.

Harvard

Teede, H. J. et al. (2026) ‘Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process’, The Lancet, 407(10545), pp. 2329–2339. doi:10.1016/s0140-6736(26)00717-8.

IEEE

H. J. Teede et al., “Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process,” The Lancet, vol. 407, no. 10545, pp. 2329–2339, 2026, doi: 10.1016/s0140-6736(26)00717-8.

BibTeX

@article{teede2026polyendocrine,
  title     = {{Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process}},
  author    = {Teede, Helena Jane and Khomami, Mahnaz Bahri and Morman, Rachel and Laven, Joop S.E. and Joham, Anju Elizabeth and Costello, Michael and Patil, Madhuri and Rees, D Aled and Berry, Lorna and Cree, Melanie G. and Zhao, Han and Norman, Robert J and Dokras, Anuja and Piltonen, Terhi and Amao, Seyi and Amiri, Mina and Andrews, Caroline and Arcari, Andrea and Arlt, Wiebke and Azziz, Ricardo and Baillargeon, Jean‐Patrice and Frcog, Adam Balen Md and Benham, Jamie Laura and Biko, Jack and Blockeel, Christophe and Bourne, Tom and Brendehaug, Ann Helen and Busby, Maureen and Campbell, Rebecca E. and Carrington, Yashi and others},
  journal   = {The Lancet},
  year      = {2026},
  volume    = {407},
  number    = {10545},
  pages     = {2329--2339},
  doi       = {10.1016/s0140-6736(26)00717-8},
  url       = {https://doi.org/10.1016/s0140-6736(26)00717-8}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders

  • polyendocrine metabolic ovarian syndrome
  • polycystic ovary syndrome
  • disease nomenclature
  • name change
  • Delphi method
  • nominal group technique
  • stigma
  • diagnostic classification

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Teede, H. J., Khomami, M. B., Morman, R., Laven, J. S., Joham, A. E., Costello, M., Patil, M., Rees, D. A., Berry, L., Cree, M. G., Zhao, H., Norman, R. J., Dokras, A., Piltonen, T., Amao, S., Amiri, M., Andrews, C., Arcari, A., Arlt, W., . . . Zhang, Y. (2026). Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. The Lancet, 407(10545), 2329–2339. https://doi.org/10.1016/s0140-6736(26)00717-8

How many times has this paper been cited?

542 times, according to OpenAlex on 16 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at The Lancet: sign in and open the PDF from this page.

Who wrote this paper?

Helena Jane Teede, Mahnaz Bahri Khomami, Rachel Morman, Joop S.E. Laven, Anju Elizabeth Joham, Michael Costello, Madhuri Patil, D Aled Rees, Lorna Berry, Melanie G. Cree, Han Zhao, Robert J Norman and 64 more.

What is the DOI of this paper?

10.1016/s0140-6736(26)00717-8, permanently at https://doi.org/10.1016/s0140-6736(26)00717-8. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 16 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.